Tumescent local anesthesia is based upon the infusion of large volumes of neutralized anesthetic solutions, mainly lidocaine, at very low concentrations. This results in the paralysis of sensory nerve endings and minute nerve twigs, leading to a reduction in pain. The aim of this study was to assess the safety of lidocaine application in tumescent local anesthesia on different regions of patient's bodies. Measures of safety included the analysis of lidocaine concentrations and its pharmacokinetic parameters. In total, 48 patients were infused with tumescent anesthesia in the hypogastrium, buttocks and thighs, axillae, breasts, trunk, and face and neck areas. Lidocaine was infused in doses ranging from 5.2-40 mg/kg b.w., and in concentrations of 0.05% (hypogastrium, buttocks, thighs) or 0.1-0.15% (axillae, breasts, trunk, face, neck), using a total amount of 300-3200 mg. As the peak lidocaine concentration did not exceed 5 microg/ml (commonly known as the toxic threshold), the results of our study indicate that the doses used (not exceeding 40 mg/kg b.w.) are completely safe for patients undergoing tumescent anesthesia in different body areas. The observation of statistically significant correlations between both the dose and the total amount of lidocaine administered and its peak plasma concentration, together with the lack of correlations between the dose and the amount and the time taken to reach peak concentration, allows the safety of each anesthetic dose to be predicted. An analysis of the heterogeneous dynamics of lidocaine plasma concentration changes in tumescent anesthesia in different body areas indicates that both the rates and the degrees of absorption and elimination depend on the area of infiltration; this is in turn related to the vascularization of any given area. The study of lidocaine concentration and pharmacokinetic parameters also showed that there may potentially be a higher risk of a large anesthetic concentration developing within a short period of time during anesthesia of the upper parts of the body. During tumescent anesthesia, significantly higher plasma concentrations of lidocaine were observed in the face and neck than in the hypogastrium, buttocks and thighs, axillae, breast and trunk 0.5 to 4 h after its infusion. This indicates the need for carefully conducted patient observations immediately after infiltration into the aforementioned areas.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s1734-1140(09)70116-1 | DOI Listing |
Burns
December 2024
Burn & Plastic, Reconstructive and Aesthetic Surgery,Azienda Ospedaliera Cannizzaro, Via Messina 829, Catania, Italy.
Introduction: Burn injuries are a global health challenge, causing significant pain, tissue damage and complex wound management issues. Traditional treatments like surgical debridement, while effective, pose challenges such as blood loss, grafting requirements, and prolonged hospital stays. Enzymatic debridement, such as the Nexobrid procedure, effectively removes necrotic tissue but can be painful for patients.
View Article and Find Full Text PDFAesthetic Plast Surg
January 2025
, 433 N Camden Dr #770, Beverly Hills, CA, 90210, USA.
Background: Venous thromboembolism (VTE) is the most feared complications of abdominoplasty, and multiple studies in the plastic surgery literature have sought to prevent these complications. General inhalational anesthesia can increase the risk of VTE via a variety of mechanisms. This study evaluates whether performing abdominoplasties under total intravenous anesthesia (TIVA) instead of general inhalational anesthesia can reduce the risk of VTE.
View Article and Find Full Text PDFWiad Lek
December 2024
STATE INSTITUTION OF SCIENCE ≪CENTER OF INNOVATIVE HEALTHCARE TECHNOLOGIES≫ STATE ADMINISTRATIVE DEPARTMENT, KYIV, UKRAINE.
Objective: Aim: To compare the effectiveness of tumescent anesthesia and regional anesthesia under ultrasound guidance in terms of their impact on nociceptive and stress systems, as well as systemic hemodynamics, in patients with chronic venous disease of the lower extremities, undergoing surgical treatment.
Patients And Methods: Materials and Methods: Fifty patients (average age 48 ±15 years; 19 [38 %] males and 31 [62 %] females) with chronic venous disease of the lower extremities, who underwent surgical treatment (endovenous laser ablation and miniphlebectomy on one limb), were examined. Twenty-five patients (main group) underwent surgery under femoral nerve block with 150 mg of lidocaine and sciatic nerve block (popliteal fossa) with 150 mg of lidocaine under ultrasound guidance.
Ann Vasc Surg
December 2024
Vascular Surgery, Department of Surgery, Frankston Hospital, Peninsula Health, Melbourne, Victoria, Australia.
Background: Treatment of symptomatic varicose veins has changed dramatically in the last few years with guidelines now recommending endovenous surgery as first-line intervention. Previously, this was achieved by laser or radiofrequency ablation of the target vein, requiring infiltration of tumescent anesthesia to reduce the risks of thermal damage to surrounding tissue. Endovenous cyanoacrylate injection (VenaSeal™) is a nonthermal, nontumescent endovenous closure technique, increasing patient comfort and is readily performed under local anesthesia only and thus is a feasible technique for in-room treatment.
View Article and Find Full Text PDFCirc Arrhythm Electrophysiol
December 2024
Division of Cardiac Electrophysiology, Department of Medicine (B.K.H., G.G., F.E.M., D.S.F., T.M.M.), University of Pennsylvania, Philadelphia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!